SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001654954-17-005155
Filing Date
2017-05-30
Accepted
2017-05-26 21:43:19
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO REGISTRATION STATEMENT FOR FOREIGN ISSUERS f-3a.htm F-3/A 92937
2 OPINION OF GOWLING WLG (CANADA) LLP AS TO THE LEGALITY OF THE SECURITIES BEING R exhibit_5-1.htm EX-5.1 25327
3 TAX OPINION OF BLANK ROME LLP exhibit_8-1.htm EX-8.1 14777
4 TAX OPINION OF GOWLING WLG (CANADA) LLP exhibit_8-2.htm EX-8.2 12634
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (MNP LLP) exhibit_23-1.htm EX-23.1 5892
6 CONSENT OF DELOITTE LLP exhibit_23-2.htm EX-23.2 7420
7 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
8 IMAGE mnp_address-1.jpg GRAPHIC 5048
9 IMAGE mnp_address-2.jpg GRAPHIC 6286
10 IMAGE mnp_logo.jpg GRAPHIC 2454
  Complete submission text file 0001654954-17-005155.txt   189606
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: F-3/A | Act: 33 | File No.: 333-218297 | Film No.: 17875419
SIC: 2834 Pharmaceutical Preparations